What insurance policy changes affect Washington D.C. providers?

This page tracks changes from major payers (including Medicaid managed care, commercial insurers, and Medicare Advantage plans) that explicitly apply to Washington D.C.. Changes include prior authorization updates, billing code additions or deletions, and reimbursement rate revisions.

How often are Washington D.C. policy changes updated?

Our scrapers run daily and publish new findings within 24 hours of detection. Each change includes an effective date where stated so you can prioritize what requires immediate action.

How do I get alerted to new Washington D.C. insurance policy changes?

Create a free alert on PolicyChanges.app and filter by state to Washington D.C.. You will get an email when new matching changes are detected: daily or weekly, your choice, on every plan.

PAYER POLICY CHANGES

Washington D.C. Insurance & Medicaid Policy Updates

Washington D.C. providers face a continuous stream of payer policy changes: coverage edits, prior authorization expansions, billing code revisions, and Medicaid reimbursement updates that affect day-to-day practice operations. This page surfaces every tracked policy change that explicitly names Washington D.C., so your billing and compliance teams can act before the effective date, not after a claim denial.

UnitedHealthcare · Effective Jan 1, 2027Medium impact
Washington, D.C.: Change in post-acute care utilization management
Starting January 1, 2027, Home and Community Care Transitions will assume utilization management responsibilities for post-acute inpatient services (skilled nursing facilities, acute inpatient rehab, long-term acute care) for three specific Dual Special Needs Plans in Washington, D.C. Previously, UnitedHealthcare managed this process. Prior authorization requests can now be submitted through the Access portal for these affected DSNPs.
Humana · Effective Oct 1, 2026High impact
Molecular Biomarkers for Prostate Cancer Risk Stratification - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage coverage policy for molecular biomarker tests used in prostate cancer risk stratification (effective 10/1/2026). The policy establishes coverage criteria for tests like ArteraAI, EpiSwitch, IsoPSA, MyProstateScore 2.0, ProMark, and ProsTAV, with coverage determinations based on MAC-specific LCDs/LCAs that vary by geographic jurisdiction. Billing teams must identify the correct MAC jurisdiction and apply the corresponding LCD requirements for each test ordered.
Humana · Effective Oct 1, 2026High impact
Bariatric Surgery - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage bariatric surgery coverage policy (HUM-1020-005) effective October 1, 2026, that outlines coverage determinations, limitations, and coding requirements for various bariatric procedures. The policy applies Humana's Medicare Advantage coverage standards and references applicable MAC Local Coverage Determinations by geographic jurisdiction, with specific rules varying by state and MAC region.
Humana · Effective Sep 1, 2026High impact
Spinal Fusion Surgery - Medicare Advantage (Revised)
This is a revised Medicare Advantage medical coverage policy for spinal fusion surgery (effective 09/01/2026) that consolidates coverage determination, limitations, coding information, and evidence summaries for cervical, lumbar, and thoracic spinal fusion procedures. The policy references multiple MAC-specific Local Coverage Determinations (LCDs) across geographic jurisdictions and outlines covered procedures including traditional fusion, minimally invasive approaches (DLIF, XLIF, MITLIF), sacroiliac joint fusion, and interlaminar fusion techniques. Billing teams must align claims submission with the applicable MAC LCD based on patient location and ensure procedures meet specific medical necessity criteria outlined in the referenced determinations.
Humana · Effective Sep 1, 2026High impact
Benign Prostatic Hyperplasia Treatments - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage coverage policy for Benign Prostatic Hyperplasia treatments effective September 1, 2026. The policy outlines coverage determinations for multiple BPH treatment modalities including surgical procedures (TURP, prostatectomy, laser therapies), temporary implanted devices, stents, and diagnostic testing. The policy references multiple MAC-specific Local Coverage Determinations (LCDs) that vary by geographic jurisdiction, requiring billing teams to verify applicable coverage rules based on patient location.
Humana · Effective Sep 1, 2026High impact
Ambulatory Cardiac Monitoring Devices - Medicare Advantage (Revised)
Humana Medicare Advantage has revised its Ambulatory Cardiac Monitoring Devices policy effective September 1, 2026. The policy provides updated coverage guidance for various cardiac monitoring technologies (Holter monitors, patch recorders, external loop monitors, implantable loop recorders, and mobile cardiac outpatient telemetry) with MAC-specific coverage determinations by geographic jurisdiction. The policy document appears incomplete but establishes that medical necessity determinations will follow applicable NCDs and LCDs based on the member's jurisdiction.
UnitedHealthcare · Effective Sep 1, 2026High impact
Medicare: New DME process for select members in multiple states
Effective September 1, 2026, Synapse Health will manage DME ordering and fulfillment for select UnitedHealthcare Medicare Advantage plans in multiple states. Providers must transition to prescribing through the Synapse Health e-prescribing portal, and DME suppliers must join the Synapse Health network to continue serving UnitedHealthcare members. This change affects Individual HMO/PPO plans, C-SNP, and D-SNP plans in 11 states, with a defined list of covered and non-covered DME categories.
Humana · Effective Aug 6, 2026High impact
Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage coverage policy for neuroablative techniques used to treat chronic pain, effective 08/06/2026. The policy defines coverage criteria, eligible procedures (including radiofrequency ablation, cryoablation, chemical neurolysis, and specialized devices like Intracept), and references MAC-specific LCDs and billing codes by geographic jurisdiction. Billing teams must verify applicable MAC guidelines for their state and ensure claims comply with local coverage determinations.
Humana · Effective Aug 6, 2026High impact
Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage policy on neuroablative techniques for chronic pain management, effective 08/06/2026. The policy defines covered denervation procedures (radiofrequency ablation, cryoablation, facet denervation, basivertebral nerve ablation, and others) and references MAC-specific LCDs and NCDs that vary by geographic jurisdiction. Billing teams must verify applicable MAC requirements for their region before processing claims for these procedures.
Humana · Effective Aug 3, 2026High impact
Genetic Testing for Hereditary Cancer - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage policy on genetic testing for hereditary cancer syndromes, effective August 3, 2026. The policy establishes coverage guidelines for germline genetic testing across multiple cancer types (melanoma, gastric cancer, neuroendocrine tumors, renal cell carcinoma, and others) and references specific MAC-based Local Coverage Determinations (LCDs) that vary by geographic jurisdiction. Billing teams must verify applicable MAC jurisdiction and LCD requirements before processing claims.
Humana · Effective Aug 3, 2026High impact
Breast Reconstruction - Medicare Advantage (Revised)
Humana Medicare Advantage has revised its breast reconstruction coverage policy (effective 08/03/2026) to clarify medical necessity criteria for reconstruction procedures following mastectomy, trauma, or congenital abnormalities. The policy applies MAC-specific Local Coverage Determinations (LCDs) by geographic jurisdiction and establishes criteria for determining coverage of implant removal, reduction mammaplasty, and related procedures. Billing teams must identify the appropriate MAC jurisdiction for each claim and apply the correct LCD requirements.
Humana · Effective Aug 3, 2026High impact
Breast Excision and Mastectomy - Medicare Advantage (Revised)
Humana Medicare Advantage has updated its Breast Excision and Mastectomy policy (HUM-1254-009) effective 08/03/2026. This revised policy clarifies coverage criteria for breast lesion excisions (CPT 19120, 19125), partial mastectomies (CPT 19301, 19302), and gynecomastia mastectomy (CPT 19300) across multiple MAC jurisdictions. The policy establishes specific medical necessity criteria based on biopsy results, lesion characteristics, and anatomical considerations, and applies jurisdiction-specific Local Coverage Determinations (LCDs) for Medicare Administrative Contractors.
Humana · Effective Aug 3, 2026High impact
Benign Prostatic Hyperplasia Treatments - Medicare Advantage (Revised)
This is a comprehensive Medicare Advantage policy for Benign Prostatic Hyperplasia (BPH) treatments that became effective on August 3, 2026. The policy outlines coverage for multiple surgical and minimally invasive treatment modalities including TURP, laser therapies, temporary implanted devices, and stents, with specific coverage determinations varying by MAC jurisdiction. Billing teams must verify applicable MAC-specific LCDs and NCDs by geographic location before processing BPH treatment claims.
CareFirst BlueCross BlueShield · Effective Apr 1, 2026High impact
Update to Prior Authorization Requirements for Healthy DC Plan Members – Effective April 1, 2026
Starting April 1, 2026, CareFirst will end the temporary waiver of prior authorization requirements for Healthy DC plan members. All services requiring prior authorization must be approved through standard CareFirst procedures before being rendered.
CareFirst BlueCross BlueShield · Effective Apr 1, 2026High impact
Reminder: Prior Authorization Requirements for Healthy DC Plan Members – Effective April 1, 2026
CareFirst is ending its temporary waiver of prior authorization requirements for Healthy DC Plan members effective April 1, 2026. All services that normally require prior authorization must now obtain approval before providing care to these plan members.
UnitedHealthcare · Identified Sep 2, 2026High impact
Hereditary cancer testing policy reminder
UnitedHealthcare is reminding providers that multigene RNA panel testing for hereditary cancer is considered unproven and will be denied. Only DNA-only hereditary cancer panels and single-gene RNA testing remain covered under applicable medical policy and prior authorization requirements.
Humana · Effective Nov 1, 2026Medium impact
Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)
Humana Medicare Advantage revised its neuroablative techniques for chronic pain policy effective 11/01/2026. The policy update describes coverage criteria, limitations, and coding guidance for multiple denervation procedures (radiofrequency ablation, cryotherapy, facet denervation, basivertebral nerve ablation, and other neuroablative techniques). The practice must verify applicable MAC LCDs by geographic jurisdiction, obtain prior authorization as required, and ensure claims are submitted with correct coding and documentation.
Humana · Effective Oct 1, 2026Medium impact
Low Frequency, Noncontact, Nonthermal Ultrasound for Wound Care - Medicare Advantage (Revised)
This is a revised Medicare Advantage policy for low frequency, noncontact, nonthermal ultrasound (MIST Therapy) for wound care, effective October 1, 2026. The policy clarifies medical necessity criteria across multiple MAC jurisdictions, requiring that standard wound care demonstrate no improvement or be contraindicated before this therapy is covered. Billing teams must ensure claims include proper documentation of failed standard care and route requests through applicable regional MACs.
Humana · Effective Aug 30, 2026Medium impact
Molecular Diagnostic Assays and Breath Testing for Transplant Rejection - Medicare Advantage (Revised)
Humana Medicare Advantage has updated its policy on molecular diagnostic assays and breath testing for transplant rejection, effective 08/30/2026. This policy establishes coverage criteria and references for gene expression profiling tests, antigen-specific T-cell function assays, breath testing (BMAC/Heartsbreath), and donor-derived cell-free DNA tests used to monitor organ transplant recipients. Billing teams must verify MAC-specific Local Coverage Determinations (LCDs) by geographic jurisdiction, as coverage and coding requirements vary significantly by region.
Humana · Effective Aug 3, 2026Medium impact
Liquid Biopsy - Medicare Advantage (Revised)
Humana Medicare Advantage has updated its Liquid Biopsy coverage policy (Policy HUM-1151-014), effective 08/03/2026. This policy establishes coverage criteria for liquid biopsy tests (blood-based biomarker analysis for cancer detection and treatment monitoring) across multiple jurisdictions under Medicare Administrative Contractors. The policy requires medical necessity documentation and adherence to MAC-specific Local Coverage Determinations, with coverage determined through analytical/clinical validity standards and DEX Registry evaluation where CMS guidance is absent.
UnitedHealthcare · Effective Jul 1, 2026Medium impact
Gender Dysphoria Treatment
This policy update clarifies coverage criteria for Gender Dysphoria treatment in Washington D.C. and New York fully-insured group plans, aligning coverage with WPATH Standards of Care and state regulatory requirements. Billing teams in these states must ensure claims are processed according to the specified WPATH standards version (most recent for D.C.; version 8 for New York) rather than conflicting internal criteria.
Humana · Effective Jun 1, 2026Medium impact
Advanced Imaging of the Chest - Medicare Advantage (Revised)
Humana Medicare Advantage updated their advanced chest imaging policy to include specific medical necessity criteria for CT scans (CPT 71260, 71270) including detailed guidelines for pulmonary nodule follow-up imaging and preoperative/postoperative indications. The policy provides structured protocols for managing incidental pulmonary nodules based on size, type, and risk factors.
Humana · Effective May 1, 2026Medium impact
Skin and Tissue Substitutes - Medicare Advantage (Revised)
Humana updated their Medicare Advantage policy for skin and tissue substitutes/cellular and tissue-based products (CTPs), establishing coverage criteria for specific products like AlloDerm, Apligraf, and Epifix. The policy defines medical necessity requirements based on local coverage determinations for diabetic foot ulcers, venous leg ulcers, breast reconstruction, and burn treatment.
Humana · Effective Mar 2, 2026Medium impact
Advanced Imaging of the Head and Neck - Medicare Advantage (Revised)
Humana has revised their Medicare Advantage policy for advanced imaging of the head and neck, establishing specific medical necessity criteria for MRA and MRI procedures. The policy provides jurisdiction-specific coverage determinations and clarifies when high-risk intracranial aneurysmal screening MRA is considered medically necessary.
Humana · Effective Feb 2, 2026Medium impact
Psychological and Neuropsychological Testing - Medicare Advantage (New)
Humana has released a new Medicare Advantage medical coverage policy for psychological and neuropsychological testing, establishing coverage criteria and billing guidelines for related CPT codes. This policy references multiple Medicare Administrative Contractor (MAC) Local Coverage Determinations across different states to determine medical necessity requirements.
UnitedHealthcare · Effective Feb 1, 2026Medium impact
AARP Medicare Supplement: Change to overpayment reimbursement process
AARP Medicare Supplement plans from UnitedHealthcare will automatically offset overpayments from future ACH electronic payments instead of sending letters requesting refunds. This streamlined process applies to providers receiving electronic payments through Optum Pay in 33 specified states.
CareFirst BlueCross BlueShield · Effective Jan 1, 2026Medium impact
2026 CareFirst BlueCross BlueShield Medicare Advantage (MA) PPO Plan Updates
CareFirst BlueCross BlueShield is updating their Individual Medicare Advantage PPO plans effective January 1, 2026, with changes to plan offerings, premiums, copays, and ID card designs. The policy introduces three plan tiers (Essential at $0, Complete at $42, Salute at $0) and emphasizes using CareFirst Direct for eligibility verification and the Prior Authorization Lookup tool for service requirements.
CareFirst BlueCross BlueShield · Effective Jan 1, 2026Medium impact
Healthy DC Plan Update
CareFirst is launching the Healthy DC Plan on January 1, 2026, for Washington D.C. residents with incomes between 138-200% of federal poverty level. The plan offers $0 premiums, copays, and deductibles, with a temporary waiver of prior authorization requirements during the initial implementation period.
UnitedHealthcare · Effective Dec 1, 2025Medium impact
District of Columbia Medicaid: Coverage criteria for skin and soft tissue substitutes
UnitedHealthcare Community Plan of District of Columbia will begin reviewing medical claims for skin and soft tissue substitutes against new coverage criteria. Claims that don't meet the outlined criteria or lack required documentation will be denied.
UnitedHealthcare · Effective Oct 1, 2025Medium impact
DC Medicaid: DME prior authorization update
Effective October 1, 2025, UnitedHealthcare DC Medicaid is aligning specific durable medical equipment (DME) prior authorization requirements with their Dual Complete Special Needs Plan requirements. This affects hospital beds, patient lifts, power wheelchairs, and respiratory support devices for DC Medicaid and integrated DSNP LTSS enrollees.
Maryland Medicaid · Identified Jun 20, 2026Medium impact
Change in Reimbursement to District of Columbia Hospitals
Maryland's Medicaid managed care program is changing reimbursement rates for District of Columbia hospitals. This affects billing and payment processes for Maryland Medicaid patients receiving services at DC hospitals.
CareFirst BlueCross BlueShield · Identified Jun 20, 2026Medium impact
Upcoming Changes to Certain BlueChoice Advantage Plans
CareFirst is changing certain BlueChoice Advantage plans from HMO to PPO designation in their system to fix member access issues with BlueCard PPO networks outside their service area. However, members within the CareFirst service area (Maryland, DC, Northern Virginia) must still follow BlueChoice HMO rules despite the system showing 'PPO'.
CareFirst BlueCross BlueShield · Identified Jun 20, 2026Medium impact
December 2024 BlueLink is Now Available
CareFirst BlueShield has published their December 2024 BlueLink newsletter containing multiple policy updates including prior authorization changes, new coverage mandates for cancer screenings, hearing aids, and cardiovascular benefits across Maryland, Virginia, and D.C.
UnitedHealthcare · Identified Jan 12, 2026Medium impact
Credentialing Plan State and Federal Regulatory Addendum: Additional State and Federal Credentialing Requirements
State insurance and HMO regulations apply to Commercial, Medicare and Medicaid products and health plans sold in each state, and the federal Medicare participation rules apply to all Medicare and Medicare/Medicaid dual eligible products. Examples of state timelines include 60 calendar days to conclude credentialing in Arizona, 60 calendar days for physicians in Colorado, and no more than 90 days for initial credentialing in New Jersey after receipt of a complete application. Maryland and North Carolina restrict requests for information beyond the uniform credentialing form, and federal rules require the information verified for a credentialing decision to be no more than 180 calendar days old at the time of the Credentialing Committee decision. California rules take effect January 1, 2027 for 90-day determinations and January 1, 2028 for use of the CAQH credentialing form.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Washington, D.C.: Change in post-acute care utilization management

Molecular Biomarkers for Prostate Cancer Risk Stratification - Medicare Advantage (Revised)

Bariatric Surgery - Medicare Advantage (Revised)

Spinal Fusion Surgery - Medicare Advantage (Revised)

Benign Prostatic Hyperplasia Treatments - Medicare Advantage (Revised)

Ambulatory Cardiac Monitoring Devices - Medicare Advantage (Revised)

Medicare: New DME process for select members in multiple states

Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)

Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)

Genetic Testing for Hereditary Cancer - Medicare Advantage (Revised)

Breast Reconstruction - Medicare Advantage (Revised)

Breast Excision and Mastectomy - Medicare Advantage (Revised)

Benign Prostatic Hyperplasia Treatments - Medicare Advantage (Revised)

Update to Prior Authorization Requirements for Healthy DC Plan Members – Effective April 1, 2026

Reminder: Prior Authorization Requirements for Healthy DC Plan Members – Effective April 1, 2026

Hereditary cancer testing policy reminder

Neuroablative Techniques for Chronic Pain - Medicare Advantage (Revised)

Low Frequency, Noncontact, Nonthermal Ultrasound for Wound Care - Medicare Advantage (Revised)

Molecular Diagnostic Assays and Breath Testing for Transplant Rejection - Medicare Advantage (Revised)

Liquid Biopsy - Medicare Advantage (Revised)

Gender Dysphoria Treatment

Advanced Imaging of the Chest - Medicare Advantage (Revised)

Skin and Tissue Substitutes - Medicare Advantage (Revised)

Advanced Imaging of the Head and Neck - Medicare Advantage (Revised)

Psychological and Neuropsychological Testing - Medicare Advantage (New)

AARP Medicare Supplement: Change to overpayment reimbursement process

2026 CareFirst BlueCross BlueShield Medicare Advantage (MA) PPO Plan Updates

Healthy DC Plan Update

District of Columbia Medicaid: Coverage criteria for skin and soft tissue substitutes

DC Medicaid: DME prior authorization update

Change in Reimbursement to District of Columbia Hospitals

Upcoming Changes to Certain BlueChoice Advantage Plans

December 2024 BlueLink is Now Available

Credentialing Plan State and Federal Regulatory Addendum: Additional State and Federal Credentialing Requirements